Corticosteroids and / or Arthrographic Distention in the Treatment of Adhesive Capsulitis
Launched by IMELDA HOSPITAL, BONHEIDEN · Nov 13, 2013
Trial Information
Current as of May 03, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pain and stiffness in predominantly 1 shoulder for 4 weeks or longer
- • Restriction of passive motion of greater than 30° in 2 or more planes of movement (measured to onset of pain with goniometer)
- Exclusion Criteria:
- • Previous arthrographic distention and/or corticosteroid injection
- • Systemic inflammatory joint disease
- • Radiological evidence of osteoarthritis of the shoulder or fracture
- • Signs of a complete rotator cuff tear
- • Contraindications to arthrogram and/or distention
- • Lack of written informed consent
About Imelda Hospital, Bonheiden
Imelda Hospital Bonheiden is a leading healthcare institution dedicated to advancing patient care through innovative research and clinical trials. With a commitment to high standards of medical excellence, the hospital fosters a collaborative environment for healthcare professionals and researchers to explore new therapies and treatments. Imelda Hospital Bonheiden prioritizes patient safety and ethical considerations, ensuring that all clinical trials are conducted in accordance with regulatory guidelines and best practices. By participating in cutting-edge research initiatives, the hospital aims to contribute significantly to the medical community and enhance treatment options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bonheiden, Antwerpen, Belgium
Patients applied
Trial Officials
Rolf Symons, MD
Principal Investigator
Imeldaziekenhuis
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials